RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review). Kausar MA, Alshammari KF, Alenazi F, Anwar S, et al. Int J Oncol 2025;67:65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kausar MA, Alshammari KF, Alenazi F, Anwar S, et al. RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review). Int J Oncol 2025;67:65.
PMID: 40613200